• Verapamil HCl Targets Txnip in Osteoporosis

  2026-09-04

  The reference study identifies Txnip as a potential molecular link between verapamil exposure and bone remodeling, combining human genetic association data, cell-based assays, and an ovariectomized mouse model. Its findings suggest that verapamil can reduce abnormal bone turnover through ChREBP-dependent signaling in osteoclasts and osteoblasts, although clinical efficacy and calcium-channel dependence remain to be established.

• VX-765: Caspase-1 Workflows and Troubleshooting

  2026-09-03

  VX-765 enables targeted investigation of caspase-1-dependent cytokine processing and pyroptosis, while its prodrug conversion adds an important experimental variable. This workflow-focused guide covers assay design, macrophage applications, disease-model interpretation, and troubleshooting for more defensible inflammation data.

• SLC2A5 and Fructose Metabolism in PCNSL

  2026-09-03

  This 2026 Advanced Science study uses single-cell RNA and B-cell receptor profiling to show how glucose-poor, hypoxic primary central nervous system lymphoma supports SLC2A5-mediated fructose metabolism in malignant cells and tumor-supportive macrophages. Genetic and pharmacologic SLC2A5 inhibition reduced lymphoma growth in functional models, identifying a metabolic vulnerability while highlighting the need for further clinical validation.

• Phillygenin in Diabetic Nephropathy: Mechanistic Evidence

  2026-09-02

  The reference study shows that phillygenin protects against diabetic nephropathy in high-glucose podocytes and db/db mice by suppressing TLR4/MyD88/NF-κB-associated inflammation while supporting PI3K/AKT/GSK3β signaling. Its combined cellular, transcriptomic, biochemical, and animal-model design provides a useful preclinical framework for connecting podocyte injury, apoptosis, inflammation, and albuminuria.

• Gemcitabine HCl in MRI-Guided PDAC Studies

  2026-09-02

  Gemcitabine HCl connects mechanism-based cytotoxicity with longitudinal MRI, enabling researchers to distinguish cell-line sensitivity from whole-tumor response in pancreatic cancer models. This workflow combines formulation control, in vitro cytotoxicity testing, and multianimal imaging for more efficient preclinical treatment studies.

• Cytochalasin D Workflows for Actin and Uptake Studies

  2026-09-01

  Cytochalasin D provides a practical way to test how actin remodeling controls nanoparticle uptake, cell morphology, proliferation, and survival. This workflow pairs concentration-controlled cytoskeletal perturbation with viability and imaging controls, helping distinguish altered endocytosis from nonspecific toxicity.

• 3-Methyladenine Sensitizes NPC Cells to Cisplatin

  2026-09-01

  A 2025 PLOS ONE study identifies 3-methyladenine as a potential modulator of the DNA damage response rather than only an autophagy-related reagent. In nasopharyngeal carcinoma cells, combining 3-methyladenine with Cisplatin reduced viability, increased mitochondrial dysfunction and apoptosis, and suppressed ATM/ATR/p53-associated repair signaling.

• FerroOrange for Live-Cell Fe²⁺ Detection

  2026-08-31

  FerroOrange is a live-cell Fe²⁺ fluorescent probe for resolving intracellular iron changes in microscopy, flow cytometry, and plate-based experiments. This guide translates a recent Cdk5–AMPK ferroptosis study into practical assay design, controls, and troubleshooting strategies without treating Fe²⁺ fluorescence as a standalone measure of cell death.

• Cell Counting Kit-8 Plus for Macrophage Studies

  2026-08-31

  Cell Counting Kit-8 Plus gives researchers a rapid, sensitive way to quantify viable macrophages during ischemia–reperfusion injury modeling, cytotoxicity testing, and intervention screening. This practical guide connects WST-8 assay design with the IRF1–NLRC5 PANoptosis pathway while emphasizing controls, normalization, and orthogonal validation.

• PX-478 in Prenatal Hypoxia–Related ASD Models

  2026-08-30

  A 2024 rat study examined whether postnatal HIF-1α inhibition with PX-478 could reduce autism-like phenotypes caused by prenatal hypoxia. The work links behavioral and hippocampal improvements to changes in HIF-1α, PTEN, and VEGF while showing that treatment timing affects tolerability.

• Annexin V Connects Cancer Metabolism to Cell Death

  2026-08-29

  Metabolic plasticity can determine whether a cancer cell survives treatment, enters a reversible growth arrest, or progresses toward apoptosis. This thought-leadership article explains how Annexin V, human recombinant can connect metabolic studies with phosphatidylserine externalization, using the CIP2A–PKM2 findings in non-small cell lung cancer as a translational framework. It covers assay design, controls, competitive advantages, limitations, and practical strategies for integrating a phosphatidylserine binding protein into cancer research and cell death workflows.

• Rhodamine B for Drift Mapping and Cell Assays

  2026-08-28

  Rhodamine B, also called Basic Violet 10, connects quantitative pesticide-drift mapping with fluorescence microscopy and cell-labeling workflows. This guide translates UAV-versus-knapsack findings into practical calibration, sampling, imaging, and troubleshooting decisions.

• ATP Solution for Translational mRNA Research

  2026-08-28

  The p21 mRNA–LNP bladder cancer study illustrates how localized delivery can turn transient gene expression into a therapeutic strategy. This thought-leadership article connects that biology to the upstream assay infrastructure required for reproducible in vitro transcription, kinase, ligation, and phosphorylation workflows, showing how ATP quality becomes a translational variable rather than a routine reagent detail.

• Gemcitabine HCl and MRI in PDAC Research

  2026-08-27

  A translational framework for using Gemcitabine HCl as a mechanistic reference treatment while multianimal MRI improves tumor enrollment, longitudinal monitoring, and preclinical decision-making in pancreatic cancer models.

• Halazone: From Chlorine Chemistry to Assay Design

  2026-08-27

  Halazone is an antimicrobial sulfonamide derivative whose value depends on understanding both active-chlorine chemistry and experimental context. This article translates its water-disinfection behavior and frog-nerve sodium-current evidence into practical decisions for reproducible biotechnology assays.

8024 records 1/535 page Next 12345 下5页 Last page